Benchmark to divest several non-core business areas

Aquaculture biotechnology company Benchmark will, over the next few years, exit or divest several business areas that are not delivering enough return on investment, CEO Malcolm Pye told IntraFish.

In 2019, Benchmark sold some production facilities in China, and exited lumpfish programs in which it was involved. The company has identified another seven or eight areas where it deems investments will not give enough return to the group, Pye said.

“We are focusing on delivering better internal efficiencies," Pye said.